News
Intraosseous Infusion Devices revenue is expected to grow by CAGR 6.2% from 2025 to 2032 and reach nearly USD 8.79 Bn. In 2032. From ER to EMS, intraosseous infusion is changing how we deliver urgent ...
The UCLA advance opens the door to growing other vascularized organ models, including intestines and colons, providing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback